Fairman Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Buy |
60
+1
| +2% | +$184 | 0.01% | 155 |
|
|
2025
Q1 | $10.4K | Sell |
59
-9
| -13% | -$1.59K | 0.01% | 146 |
|
|
2024
Q4 | $12K | Sell |
68
-9
| -12% | -$1.59K | 0.01% | 149 |
|
|
2024
Q3 | $15.2K | Hold |
77
| – | – | 0.01% | 150 |
|
|
2024
Q2 | $13.1K | Buy |
77
+1
| +1% | +$171 | 0.01% | 156 |
|
|
2024
Q1 | $13.8K | Sell |
76
-420
| -85% | -$76.5K | 0.01% | 143 |
|
|
2023
Q4 | $76.8K | Buy |
+496
| New | +$76.8K | 0.07% | 85 |
|